Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ragada El-Damanawi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Kidney Journal|February 26, 2015
Successful restoration of arteriovenous dialysis access patency after late interventionRagada El-Damanawi, Stephanie Kershaw, Gary Campbell, et al.
Clinical Kidney Journal|June 16, 2017
Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs surveyRagada El-Damanawi, Tess Harris, Richard N Sandford, et al.
Nephron|February 28, 2015
Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal diseasePeter A G Galloway, Ragada El-Damanawi, Victoria Bardsley, et al.
Kidney International Reports|November 24, 2025
End Point Selection in ADPKD Clinical TrialsKitty St Pierre, Ragada El-Damanawi, Julia Jefferis, et al.
Kidney International Reports|April 29, 2021
Per-Treatment <i>Post Hoc</i> Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKDAndrew J Mallett, Ronald D Perrone, Gopala Rangan, et al.
The Cochrane Database of Systematic Reviews|June 5, 2024
Metformin for preventing the progression of chronic kidney diseaseRagada El-Damanawi, Isabelle Kitty Stanley, Christine Staatz, et al.
BMJ Open|May 11, 2018
Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trialRagada El-Damanawi, Michael Lee, Tess Harris, et al.
Clinical Kidney Journal|November 10, 2021
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney diseaseRagada El-Damanawi, Michael Lee, Tess Harris, et al.
Trials|August 26, 2025
Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney diseaseKitty St Pierre, Ragada El-Damanawi, David W Johnson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 11, 2020
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus WorkshopYeoungjee Cho, Allison Tong, Jonathan C Craig, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Kidney Journal|February 26, 2015
Successful restoration of arteriovenous dialysis access patency after late interventionRagada El-Damanawi, Stephanie Kershaw, Gary Campbell, et al.
Clinical Kidney Journal|June 16, 2017
Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs surveyRagada El-Damanawi, Tess Harris, Richard N Sandford, et al.
Nephron|February 28, 2015
Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal diseasePeter A G Galloway, Ragada El-Damanawi, Victoria Bardsley, et al.
Kidney International Reports|November 24, 2025
End Point Selection in ADPKD Clinical TrialsKitty St Pierre, Ragada El-Damanawi, Julia Jefferis, et al.
Kidney International Reports|April 29, 2021
Per-Treatment <i>Post Hoc</i> Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKDAndrew J Mallett, Ronald D Perrone, Gopala Rangan, et al.
The Cochrane Database of Systematic Reviews|June 5, 2024
Metformin for preventing the progression of chronic kidney diseaseRagada El-Damanawi, Isabelle Kitty Stanley, Christine Staatz, et al.
BMJ Open|May 11, 2018
Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trialRagada El-Damanawi, Michael Lee, Tess Harris, et al.
Clinical Kidney Journal|November 10, 2021
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney diseaseRagada El-Damanawi, Michael Lee, Tess Harris, et al.
Trials|August 26, 2025
Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney diseaseKitty St Pierre, Ragada El-Damanawi, David W Johnson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 11, 2020
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus WorkshopYeoungjee Cho, Allison Tong, Jonathan C Craig, et al.
Pageof 1